{
    "Trade/Device Name(s)": [
        "VisuCon-F Frozen Coag Screen N",
        "VisuCon-F Frozen Coag Screen ABN"
    ],
    "Submitter Information": "Affinity Biologicals Inc.",
    "510(k) Number": "K110432",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082859"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN"
    ],
    "Summary Letter Date": "October 20, 2011",
    "Summary Letter Received Date": "October 12, 2011",
    "Submission Date": "October 11, 2011",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin time (PT)",
        "Activated partial thromboplastin time (APTT)",
        "Fibrinogen"
    ],
    "Specimen Type(s)": [
        "Citrated human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for VisuCon-F Frozen Coag Screen N and ABN, assayed normal and abnormal control plasmas for quality control of quantitative coagulation assays.",
    "Indications for Use Summary": "Assayed normal or abnormal control plasma for use in the quality control of quantitative coagulation assays (PT, APTT, and fibrinogen), in the normal or mid-level abnormal range, used with mechanical and photo-optical coagulation instruments and commercial reagents.",
    "fda_folder": "Hematology"
}